{
    "medical_history": {
        "chief_complaint": "Signs and symptoms of acromegaly.",
        "history_of_present_illness": "The patient was admitted at the age of 49, in 1997, with confirmed acromegaly symptoms; these symptoms had progressed and were confirmed by hormonal data. The patient underwent pituitary surgery which resulted in only partial tumor removal. Treatment with octreotide for 12 months did not significantly alter GH and IGF-I levels or tumor size.",
        "past_medical_history": "The patient underwent pituitary surgery with partial tumor removal. She was previously treated with somatostatin analogs (octreotide), but showed no modifications in hormone levels during treatment. After the interruption of octreotide therapy, she received cabergoline, which resulted in reduced GH and IGF-I levels.",
        "family_history": "The patient was the only child of two unrelated parents, both of whom died of cardiovascular diseases. Genetic analysis of the patient's daughter revealed no substitutions in the sst5 gene, indicating no relevant familial history of similar symptoms.",
        "social_history": "Not specified."
    }
}